What is Steris Corp. share price today?

Steris Corp. (STE) share price today is {{live_price}}.

Can Indians buy Steris Corp. shares?

Yes, Indians can invest in the Steris Corp. (STE) from India. With INDmoney, you can buy Steris Corp. at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Steris Corp. at zero transaction cost.

How can I buy Steris Corp. shares from India?

It is very easy to buy Steris Corp. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Steris Corp. be purchased?

Yes, you can buy fractional shares of Steris Corp. with INDmoney app.

What are the documents required to start investing in Steris Corp. stocks?

To start investing in Steris Corp., You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Steris Corp.

Today’s highest price of Steris Corp. (STE) is {{1_rba_end}}. Today’s lowest price of Steris Corp. (STE) is {{1_rba_st}}.

What is today's market capitalisation of Steris Corp.

Today's market capitalisation of Steris Corp. STE is 22.3B

What is the 52 Week High and Low Range of Steris Corp.

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Steris Corp. is down from its 52 Week High?

Steris Corp. (STE) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Steris Corp. is up from its 52 Week low?

Steris Corp. (STE) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Steris Corp.?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Steris Corp.

Mr. Daniel A. Carestio is the current Chief Executive Officer (CEO) of Steris Corp..

Home>
US Stocks>
Steris Corp.

Steris Corp. (STE)

$224.64

-1.01

(-0.45%)▲

Live

Performance

$223.43
$225.41
$224.64
0.54%
Downside
Day's Volatility :0.88%
Upside
0.34%
$195.47
$248.24
$224.64
12.99%
Downside
52 Weeks Volatility :21.26%
Upside
9.51%

Returns

Period	Steris Corp.	Sector (Health Care)	S&P500
3 Months	-1.36%	3.6%	6.5%
6 Months	12.32%	10.2%	18.1%
1 Year	5.07%	19.6%	38.8%
3 Years	-2.85%	16.8%	28.9%

Highlights

Market Capitalization	22.3B
Book Value	$64.32
Dividend Share	2.08
Dividend Yield	1.01%
Earnings Per Share (EPS)	5.65
PE Ratio	39.94
PEG Ratio	9.81
Wall Street Target Price	247.3

Profit Margin	7.64%
Operating Margin TTM	16.87%

Return On Assets TTM	5.52%
Return On Equity TTM	8.97%

Revenue TTM	5.2B
Revenue Per Share TTM	52.97
Quarterly Revenue Growth YOY	8.1%
Gross Profit TTM	2.2B
EBITDA	1.3B
Diluted Eps TTM	5.65
Quarterly Earnings Growth YOY	0.18

EPS Estimate Current Year	8.6
EPS Estimate Next Year	9.33
EPS Estimate Current Quarter	1.98
EPS Estimate Next Quarter	2.17

Analyst Recommendation

Buy

58%Buy

41%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Steris Corp.(by analysts ranked 0 to 5 stars)

Based on 12 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 10.09%

Current $224.64

Target $247.30

Company Financials

	FY19	Y/Y Change
Revenue	2.8B	↑ 6.19%
Net Income	304.1M	↑ 4.52%
Net Profit Margin	10.93%	↓ 0.17%

	FY20	Y/Y Change
Revenue	3.0B	↑ 8.94%
Net Income	407.7M	↑ 34.08%
Net Profit Margin	13.45%	↑ 2.52%

	FY21	Y/Y Change
Revenue	3.1B	↑ 2.53%
Net Income	397.4M	↓ 2.52%
Net Profit Margin	12.79%	↓ 0.66%

	FY22	Y/Y Change
Revenue	4.6B	↑ 47.55%
Net Income	243.9M	↓ 38.63%
Net Profit Margin	5.32%	↓ 7.47%

	FY23	Y/Y Change
Revenue	5.0B	↑ 8.13%
Net Income	107.0M	↓ 56.12%
Net Profit Margin	2.16%	↓ 3.16%

	FY24	Y/Y Change
Revenue	5.1B	↑ 3.65%
Net Income	378.2M	↑ 253.4%
Net Profit Margin	7.36%	↑ 5.2%

	Q1 FY23	Q/Q Change
Revenue	1.4B	↑ 13.89%
Net Income	187.2M	↑ 51.81%
Net Profit Margin	13.52%	↑ 3.38%

	Q2 FY23	Q/Q Change
Revenue	1.3B	↓ 7.24%
Net Income	123.6M	↓ 34.01%
Net Profit Margin	9.62%	↓ 3.9%

	Q3 FY23	Q/Q Change
Revenue	1.3B	↑ 4.5%
Net Income	115.3M	↓ 6.67%
Net Profit Margin	8.59%	↓ 1.03%

	Q4 FY23	Q/Q Change
Revenue	1.4B	↑ 3.97%
Net Income	140.7M	↑ 22.05%
Net Profit Margin	10.08%	↑ 1.49%

	Q1 FY24	Q/Q Change
Revenue	1.4B	↑ 1.7%
Net Income	-1.4M	↓ 100.98%
Net Profit Margin	-0.1%	↓ 10.18%

	Q2 FY24	Q/Q Change
Revenue	1.3B	↓ 9.86%
Net Income	145.4M	↓ 10659.26%
Net Profit Margin	11.36%	↑ 11.46%

	FY19	Y/Y Change
Total Assets	5.1B	↓ 2.45%
Total Liabilities	1.9B	↓ 4.83%

	FY20	Y/Y Change
Total Assets	5.4B	↑ 6.95%
Total Liabilities	2.0B	↑ 6.97%

	FY21	Y/Y Change
Total Assets	6.6B	↑ 21.18%
Total Liabilities	2.7B	↑ 32.9%

	FY22	Y/Y Change
Total Assets	11.5B	↑ 74.2%
Total Liabilities	4.9B	↑ 82.93%

	FY23	Y/Y Change
Total Assets	10.8B	↓ 5.51%
Total Liabilities	4.7B	↓ 3.53%

	FY24	Y/Y Change
Total Assets	11.1B	↑ 2.23%
Total Liabilities	4.7B	↑ 0.29%

	Q1 FY23	Q/Q Change
Total Assets	10.8B	↑ 0.2%
Total Liabilities	4.7B	↓ 0.35%

	Q2 FY23	Q/Q Change
Total Assets	10.8B	↓ 0.35%
Total Liabilities	4.6B	↓ 2.72%

	Q3 FY23	Q/Q Change
Total Assets	11.3B	↑ 4.6%
Total Liabilities	5.1B	↑ 10.54%

	Q4 FY23	Q/Q Change
Total Assets	11.4B	↑ 1.37%
Total Liabilities	5.0B	↓ 1.66%

	Q1 FY24	Q/Q Change
Total Assets	11.1B	↓ 3.25%
Total Liabilities	4.7B	↓ 5.17%

	Q2 FY24	Q/Q Change
Total Assets	10.1B	↓ 8.63%
Total Liabilities	3.7B	↓ 21.27%

	FY19	Y/Y Change
Operating Cash Flow	539.5M	↑ 17.89%
Investing Cash Flow	-213.2M	↑ 4.61%
Financing Cash Flow	-294.8M	↓ 17.24%

	FY20	Y/Y Change
Operating Cash Flow	590.6M	↑ 9.46%
Investing Cash Flow	-319.7M	↑ 49.95%
Financing Cash Flow	-163.1M	↓ 44.66%

	FY21	Y/Y Change
Operating Cash Flow	689.6M	↑ 16.78%
Investing Cash Flow	-1.2B	↑ 260.97%
Financing Cash Flow	345.6M	↓ 311.85%

	FY22	Y/Y Change
Operating Cash Flow	684.8M	↓ 0.7%
Investing Cash Flow	-666.6M	↓ 42.25%
Financing Cash Flow	115.8M	↓ 66.49%

	FY23	Y/Y Change
Operating Cash Flow	756.9M	↑ 10.53%
Investing Cash Flow	-383.3M	↓ 42.49%
Financing Cash Flow	-498.7M	↓ 530.56%

	Q1 FY23	Q/Q Change
Operating Cash Flow	215.8M	↑ 4.97%
Investing Cash Flow	-77.6M	↓ 21.17%
Financing Cash Flow	-191.9M	↑ 59.41%

	Q2 FY23	Q/Q Change
Operating Cash Flow	281.1M	↑ 30.27%
Investing Cash Flow	-66.6M	↓ 14.16%
Financing Cash Flow	-213.6M	↑ 11.3%

	Q3 FY23	Q/Q Change
Operating Cash Flow	146.1M	↓ 48.03%
Investing Cash Flow	-672.8M	↑ 910.32%
Financing Cash Flow	470.2M	↓ 320.1%

Technicals Summary

Sell

Neutral

Buy

Steris Corp. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Steris Corp.	-5.74%	12.32%	5.07%	-2.85%	60.55%
Stryker Corporation	0.83%	12.78%	40.21%	33.69%	71.83%
Boston Scientific Corp.	4.85%	29.48%	75.68%	96.28%	127.87%
Edwards Lifesciences Corp.	4.32%	-19.19%	1.77%	-39.29%	-7.22%
Abbott Laboratories	3.99%	11.51%	24.65%	-4.53%	46.22%
Medtronic Plc	2.65%	14.48%	27.42%	-24.18%	-13.49%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Steris Corp.	39.94	39.94	9.81	8.6	0.09	0.06	0.01	64.32
Stryker Corporation	40.15	40.15	2.64	12.01	0.19	0.07	0.01	51.86
Boston Scientific Corp.	70.26	70.26	2.14	2.41	0.09	0.05	NA	13.85
Edwards Lifesciences Corp.	27.67	27.67	3.65	2.6	0.22	0.12	NA	12.35
Abbott Laboratories	35.83	35.83	4.31	4.67	0.14	0.06	0.02	22.26
Medtronic Plc	30.23	30.23	1.67	5.2	0.08	0.04	0.03	37.39

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Steris Corp.	Buy	$22.3B	60.55%	39.94	7.64%
Stryker Corporation	Buy	$137.1B	71.83%	40.15	16.12%
Boston Scientific Corp.	Buy	$127.3B	127.87%	70.26	12.0%
Edwards Lifesciences Corp.	Buy	$42.3B	-7.22%	27.67	23.74%
Abbott Laboratories	Buy	$205.1B	46.22%	35.83	13.65%
Medtronic Plc	Buy	$115.2B	-13.49%	30.23	12.06%

Insights on Steris Corp.

Decreasing Revenue
Revenue is down for the last 2 quarters, 1.41B → 1.27B (in $), with an average decrease of 9.9% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -1.37M → 145.40M (in $), with an average increase of 101.0% per quarter
Vs BSX
In the last 1 year, Boston Scientific Corp. has given 76.0% return, outperforming this stock by 72.0%
Vs BSX
In the last 3 years, Boston Scientific Corp. has given 96.3% return, outperforming this stock by 99.2%

Institutional Holdings

Vanguard Group Inc
12.17%
BlackRock Inc
9.32%
Massachusetts Financial Services Company
6.53%
WCM Investment Management
4.77%
State Street Corp
4.13%
Morgan Stanley - Brokerage Accounts
3.80%

Corporate Announcements

Steris Corp. Dividends March,2024
In the quarter ending March,2024. Steris Corp. has declared dividend of $0.52
Read More

Organization	Steris Corp.
Employees	18000
CEO	Mr. Daniel A. Carestio
Industry	Health Technology

Steris Corp. (STE)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Company Financials

Technicals Summary

Peers

Decreasing Revenue

Increasing Net Profit

Vs BSX

Vs BSX

Institutional Holdings

Corporate Announcements

Steris Corp. Dividends March,2024

Company Information

Discover More

FAQs